For years, scientists have hoped to harness the immune system to attack cancer using a group of drugs known as CD40 agonist ...

Lakeshore Bone and Joint Institute has been selected as one of the 45 U.S. sites for a new clinical study evaluating the use of mesenchymal precursor cells (a type of stem cells) in subjects with ...

Iran – A new randomized clinical trial published in Dermatologic Therapy has found that intramuscular pantothenic acid ...

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

H LUNDBECK A/S (($HLUYY)) announced an update on their ongoing clinical study. H. Lundbeck A/S is currently conducting a clinical trial titled ...

The NHS is to trial “robo minders” to keep an eye on dementia patients in their own homes. The technology will allow hospital ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

New research from Dana-Farber Cancer Institute shows that a new class of drug results in cell death in cancers, such as small ...

In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s ...